Antengene Corporation Limited (HKG:6996)
Hong Kong · Delayed Price · Currency is HKD 5.94
-0.06 (-1.00%)
Apr 17, 2026, 4:08 PM HKT
Antengene Corporation Market Cap
Antengene Corporation has a market cap or net worth of 4.08 billion as of April 17, 2026. Its market cap has increased by 71.38% in one year.
Market Cap
4.08B
Enterprise Value
3.55B
Revenue
117.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.94
Market Cap Chart
Since November 20, 2020, Antengene Corporation's market cap has decreased from 12.21B to 4.08B, a decrease of -66.63%. That is a compound annual growth rate of -18.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 4.08B | 58.31% |
| Dec 31, 2025 | 2.57B | 482.90% |
| Dec 31, 2024 | 441.64M | -67.28% |
| Dec 29, 2023 | 1.35B | -61.17% |
| Dec 30, 2022 | 3.48B | -46.78% |
| Dec 31, 2021 | 6.53B | -43.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shandong Boan Biotechnology | 4.53B |
| Beijing Luzhu Biotechnology | 4.36B |
| Qyuns Therapeutics | 4.35B |
| TYK Medicines | 4.24B |
| Viva Biotech Holdings | 3.99B |
| Clover Biopharmaceuticals | 3.98B |
| BioDlink International Company | 3.78B |
| AIM Vaccine | 3.73B |